Intracellular delivery of drugs by chitosan-based multi-liposomal complexes

Colloids Surf B Biointerfaces. 2020 Sep:193:111062. doi: 10.1016/j.colsurfb.2020.111062. Epub 2020 May 5.

Abstract

Positively charged linear chitosan molecules were cross-linked with sulfate-anions to form chitosan nanoparticles which were used as a scaffold of negatively charged cardiolipin/egg lecithin liposomes loaded with doxorubicin (DOX). Thus formed multi-liposomal complexes (MLCs) containing 55 liposomes/chitosan and bearing a slight positive net charge effectively transmitted DOX into the cytoplasm of cells in culture. The efficiency of DOX delivery increased 4-5-fold upon drug incorporation in MLCs. Inside the cells, the penetrated MLCs released DOX thus enabling its accumulation in the nuclei and interaction with its intracellular target DNA leading to a decrease in cell survival. The effects were demonstrated on 3T3 line of mouse fibroblasts, drug sensitive tumor MCF-7 cells and drug resistant human ovarian carcinoma OVCAR-8 cells (formerly called MCF-7/ADR). Thus, MLC particles can be used for effective delivery of payloads in cells of different origin.

Keywords: Chitosan; Doxorubicin; Drug delivery; Liposomes; Multi-liposomal complexes; Multidrug resistance.

MeSH terms

  • 3T3 Cells
  • Animals
  • Antibiotics, Antineoplastic / chemistry
  • Antibiotics, Antineoplastic / pharmacology*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Chitosan / chemistry*
  • Doxorubicin / chemistry
  • Doxorubicin / pharmacology*
  • Drug Carriers / chemistry
  • Drug Delivery Systems*
  • Drug Screening Assays, Antitumor
  • Female
  • Humans
  • Liposomes / chemistry
  • Mice
  • Microscopy, Confocal
  • Particle Size
  • Surface Properties

Substances

  • Antibiotics, Antineoplastic
  • Drug Carriers
  • Liposomes
  • Doxorubicin
  • Chitosan